Stocks · News reference
Conmed Q2 Adj. EPS $1.38 Beats $1.11 Estimate, Sales $343.488M Beat $337.564M Estimate
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Conmed shares are trading higher after Wells Fargo raised its price target on the stock from $39 to $46.
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46
Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est